Biogen
BIIB
BIIB
1,083 hedge funds and large institutions have $40.6B invested in Biogen in 2019 Q1 according to their latest regulatory filings, with 118 funds opening new positions, 389 increasing their positions, 437 reducing their positions, and 164 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% less capital invested
Capital invested by funds: $52.2B → $40.6B (-$11.7B)
24% less funds holding in top 10
Funds holding in top 10: 29 → 22 (-7)
28% less first-time investments, than exits
New positions opened: 118 | Existing positions closed: 164
Holders
1,083
Holding in Top 10
22
Calls
$1.15B
Puts
$1.28B
Top Buyers
| 1 | +$250M | |
| 2 | +$210M | |
| 3 | +$206M | |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$177M |
| 5 |
D.E. Shaw & Co
New York
|
+$154M |
Top Sellers
| 1 | -$382M | |
| 2 | -$265M | |
| 3 | -$208M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$192M |
| 5 |
O
OrbiMed
New York
|
-$177M |